Sotheby's Offers Response to Loeb's Third Point: Says Poison Pill is 'Important Tool' to Ensure Holders Treated Fairly

Sotheby's (NYSE: BID) issued the following in response to reports that Third Point has filed litigation against the Company. Late ...